For U.S. patients with diabetic foot ulcers that are not healing, La Pradera offers Cuba's Heberprot-P therapy combined with specialized wound care — an international treatment option designed to support ulcer healing.
1.5 million
adults with diagnosed diabetes in New York
New York
NY · U.S. Priority Market
Flights from JFK and Newark (EWR) to Havana connect through Miami or Fort Lauderdale.
An estimated 1.5 million New York adults have diagnosed diabetes, with significant prevalence in urban and rural communities.
Diabetic foot ulcers that are not healing can be a serious concern. La Pradera's diabetic foot ulcer program combines Cuba's Heberprot-P therapy — a treatment designed to support the healing of diabetic foot ulcers — with specialized wound care, infection management, and rehabilitation. The program is designed for international patients whose ulcers have not responded to standard treatment. Each treatment plan is personalized following a comprehensive assessment of the ulcer, the patient's overall health, and contributing factors.
Intralesional injections designed to support the healing of diabetic foot ulcers.
Professional wound debridement to remove dead tissue and support healing.
Specialized wound dressings selected based on the ulcer type and condition.
Offloading strategies and foot care protocols to support healing and prevent recurrence.
Submit medical records and wound photos for review to assess eligibility.
Comprehensive assessment of the ulcer, wound status, blood flow, and infection risk.
Multi-week program of Heberprot-P injections, wound care, and monitoring under medical supervision.
Ongoing wound monitoring, progress assessment, and education on preventing recurrence.
Flights from JFK and Newark (EWR) to Havana connect through Miami or Fort Lauderdale.
Departure Airports:
La Pradera's international patient services team assists New York families with travel coordination, documentation, and all logistics for medical travel to Havana.
Heberprot-P is a Cuban-developed medication containing recombinant human epideral growth factor, administered by intralesional injection, designed to support the healing of diabetic foot ulcers.
Heberprot-P is designed to support the healing of diabetic foot ulcers, including those that have not responded to standard treatment. Eligibility is determined through medical records review.
Treatment programs typically range from 2 to 4 weeks, depending on the ulcer size, severity, and individual response. The exact duration is determined after assessment.
The program includes infection management as part of the comprehensive care plan. Infections are evaluated and treated alongside ulcer therapy to support healing.
Submit medical records and wound photos through the consultation request form. The international patient services team will guide you through the process and assess eligibility.
Contact our international patient services team to discuss treatment options in Cuba for you or your loved one.
We use cookies to improve your experience and analyze traffic. By continuing, you agree to our use of cookies. Privacy Policy